Volume 6, Issue 2 (12-2019)                   vacres 2019, 6(2): 23-36 | Back to browse issues page

XML Print

Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Antony J. Immunobiological Correlates of SIV Vaccine Vectors and Macaque Tropism. vacres 2019; 6 (2) :23-36
URL: http://vacres.pasteur.ac.ir/article-1-190-en.html
University of Toronto,1 King’s College Circle, Toronto ON M5S1A8. VBI Vaccines Inc. Ottawa ON Canada
Abstract:   (7270 Views)
The field of HIV vaccines received a “boost” with around 30% protection obtained in the RV144 randomized, double-blind, efficacy trial in Thailand. Currently, 560 clinical trials in HIV vaccine development are registered as complete and results are expected from several of these studies. The modest success attained at this time may be attributed to early attempts at identifying an animal model to test vaccine efficacy. Macaque models of HIV-1 infection have revealed viral infection, transmission, pathogenesis, and prevention. Identification of simian immunodeficiency virus (SIV) and its related strains served as the macaque counterpart of HIV and through genetic engineering, enabled chimera development that explored how macaques respond to a human antigen as well. Along with understanding viral infection, it is worth exploring the genetic repertoire of macaques for determining how the major histocompatibility complex and anti-retroviral restriction factors offer barriers to viral replication.
Full-Text [PDF 558 kb]   (484 Downloads)    
Type of Study: Review article | Subject: Immunologic studies and animal models
Received: 2020/03/29

Add your comments about this article : Your username or Email:

Send email to the article author

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2022 All Rights Reserved | Vaccine Research

Designed & Developed by : Yektaweb

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.